KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 131 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 1.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $196,000 | -28.2% | 57,626 | -13.7% | 0.00% | -50.0% |
| Q1 2018 | $273,000 | +143.8% | 66,812 | +176.7% | 0.00% | +100.0% |
| Q4 2017 | $112,000 | -46.2% | 24,148 | -17.6% | 0.00% | -50.0% |
| Q3 2017 | $208,000 | -24.9% | 29,300 | -23.5% | 0.00% | -20.0% |
| Q2 2017 | $277,000 | +20.4% | 38,311 | +2.8% | 0.01% | -16.7% |
| Q1 2017 | $230,000 | -25.6% | 37,275 | -29.3% | 0.01% | -53.8% |
| Q4 2016 | $309,000 | +15.7% | 52,738 | +30.5% | 0.01% | -23.5% |
| Q2 2016 | $267,000 | -8.2% | 40,400 | -35.2% | 0.02% | -26.1% |
| Q1 2016 | $291,000 | -28.1% | 62,300 | -22.3% | 0.02% | -47.7% |
| Q4 2015 | $405,000 | – | 80,151 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $3 | 0.00% |